• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过分析H2FPEF评分预测罗马尼亚射血分数保留的心力衰竭患者的生活质量

Predicting Quality of Life of Patients in Romania with Heart Failure with Preserved Ejection Fraction by Analyzing H2FPEF Scores.

作者信息

Ciobanu-Teașă Alina, Guberna Suzana, Jercălău Cosmina Elena, Ceban Octavian, Andrei Cătălina Liliana, Sinescu Crina Julieta

机构信息

Department of Cardiology, University of Medicine and Pharmacy "Carol Davila", Emergency Hospital "Bagdasar-Arseni", 020021 Bucharest, Romania.

Economic Cybernetics and Informatics Department, The Bucharest University of Economic Studies, 010552 Bucharest, Romania.

出版信息

Healthcare (Basel). 2025 Apr 15;13(8):909. doi: 10.3390/healthcare13080909.

DOI:10.3390/healthcare13080909
PMID:40281858
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12026482/
Abstract

: This study aimed to find a way to predict the quality-of-life factors for patients with heart failure with preserved ejection fraction based on their H2FPEF scores. : We performed a prospective observational analysis of 142 hospitalized patients diagnosed with HFPEF who were followed for 12 months after discharge. We calculated the H2FPEF score for each patient during hospitalization. The follow-up after discharge aimed to monitor limitations of usual physical activity, recently experienced fatigue, the presence of leg edemas, the ability to exercise regularly, and sadness. We thus obtained data about these patients' quality of life, their physical and mental limitations, their number of readmissions, and the percentage of mortality. We used logistic regression models to estimate the relationship between the H2FPEF score and each variable, providing probabilities for each sign or symptom of the disease mentioned by the patients. : All the observed variables showed statistical significance. Marked limitations of physical activity showed the strongest relationship with the H2FPEF score, followed by edema and regular exercise. Our research shows a method with which to predict the quality-of-life (QoL) factors in patients with HFPEF based on their H2FPEF scores. We can predict which patients are at high risk and require more medical resources by quickly calculating their H2FPEF scores.

摘要

本研究旨在找到一种基于H2FPEF评分来预测射血分数保留的心力衰竭患者生活质量因素的方法。我们对142例诊断为HFPEF的住院患者进行了前瞻性观察分析,在出院后对他们进行了12个月的随访。我们在住院期间计算了每位患者的H2FPEF评分。出院后的随访旨在监测日常身体活动的限制、近期经历的疲劳、腿部水肿的存在、定期锻炼的能力以及悲伤情绪。我们由此获得了这些患者的生活质量、身心限制、再入院次数以及死亡率百分比的数据。我们使用逻辑回归模型来估计H2FPEF评分与每个变量之间的关系,为患者提到的疾病的每个体征或症状提供概率。所有观察到的变量均具有统计学意义。身体活动的明显限制与H2FPEF评分的关系最为密切,其次是水肿和定期锻炼。我们的研究展示了一种基于H2FPEF评分来预测HFPEF患者生活质量(QoL)因素的方法。通过快速计算他们的H2FPEF评分,我们可以预测哪些患者处于高风险并需要更多医疗资源。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a41/12026482/59573f8f6956/healthcare-13-00909-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a41/12026482/8224d3db3770/healthcare-13-00909-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a41/12026482/41b435768610/healthcare-13-00909-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a41/12026482/9a9af612b239/healthcare-13-00909-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a41/12026482/d9af796b1dac/healthcare-13-00909-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a41/12026482/e3fce9311af3/healthcare-13-00909-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a41/12026482/da62d0045060/healthcare-13-00909-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a41/12026482/5a1d329495c7/healthcare-13-00909-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a41/12026482/3753de93ba95/healthcare-13-00909-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a41/12026482/236b017268e9/healthcare-13-00909-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a41/12026482/7a03e3bf817d/healthcare-13-00909-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a41/12026482/736cf2a141a6/healthcare-13-00909-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a41/12026482/cfa4a22ece5f/healthcare-13-00909-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a41/12026482/cc50d68562ed/healthcare-13-00909-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a41/12026482/c222b0aeb2ad/healthcare-13-00909-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a41/12026482/8f960fd1b366/healthcare-13-00909-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a41/12026482/031b10b8cf75/healthcare-13-00909-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a41/12026482/59573f8f6956/healthcare-13-00909-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a41/12026482/8224d3db3770/healthcare-13-00909-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a41/12026482/41b435768610/healthcare-13-00909-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a41/12026482/9a9af612b239/healthcare-13-00909-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a41/12026482/d9af796b1dac/healthcare-13-00909-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a41/12026482/e3fce9311af3/healthcare-13-00909-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a41/12026482/da62d0045060/healthcare-13-00909-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a41/12026482/5a1d329495c7/healthcare-13-00909-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a41/12026482/3753de93ba95/healthcare-13-00909-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a41/12026482/236b017268e9/healthcare-13-00909-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a41/12026482/7a03e3bf817d/healthcare-13-00909-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a41/12026482/736cf2a141a6/healthcare-13-00909-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a41/12026482/cfa4a22ece5f/healthcare-13-00909-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a41/12026482/cc50d68562ed/healthcare-13-00909-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a41/12026482/c222b0aeb2ad/healthcare-13-00909-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a41/12026482/8f960fd1b366/healthcare-13-00909-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a41/12026482/031b10b8cf75/healthcare-13-00909-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a41/12026482/59573f8f6956/healthcare-13-00909-g017.jpg

相似文献

1
Predicting Quality of Life of Patients in Romania with Heart Failure with Preserved Ejection Fraction by Analyzing H2FPEF Scores.通过分析H2FPEF评分预测罗马尼亚射血分数保留的心力衰竭患者的生活质量
Healthcare (Basel). 2025 Apr 15;13(8):909. doi: 10.3390/healthcare13080909.
2
[Applicability of HFPEF and HFA-PEFF Scores in Chinese Patients Suffering From Heart Failure With Preserved Ejection Fraction and Heart Failure With Preserved Ejection Fraction Complicated With Atrial Fibrillation].[射血分数保留的心力衰竭及合并心房颤动的射血分数保留的心力衰竭患者中HFPEF和HFA-PEFF评分的适用性]
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2024 Apr;46(2):154-160. doi: 10.3881/j.issn.1000-503X.15826.
3
Evaluating the Prognostic Value of the Modified HFPEF Score in Patients With Heart Failure With Preserved Ejection Fraction.评估改良HFPEF评分在射血分数保留的心力衰竭患者中的预后价值。
Cardiol Res. 2024 Oct;15(5):358-368. doi: 10.14740/cr1635. Epub 2024 Sep 16.
4
Long-term prognostic value of the HFPEF score in patients undergoing transcatheter aortic valve implantation.经导管主动脉瓣植入术患者 HFPEF 评分的长期预后价值。
ESC Heart Fail. 2024 Aug;11(4):2159-2171. doi: 10.1002/ehf2.14773. Epub 2024 Apr 12.
5
Clinical Trajectory and Risk Stratification for Heart Failure with Preserved Ejection Fraction in a Real-World Cohort of Patients with Suspected Coronary Artery Disease.疑似冠状动脉疾病真实世界队列中射血分数保留的心力衰竭的临床轨迹和风险分层
J Clin Med. 2024 Apr 3;13(7):2092. doi: 10.3390/jcm13072092.
6
H2FPEF Score Reflects the Left Atrial Strain and Predicts Prognosis in Patients With Heart Failure With Preserved Ejection Fraction.H2FPEF 评分反映左心房应变,可预测射血分数保留心力衰竭患者的预后。
J Card Fail. 2021 Feb;27(2):198-207. doi: 10.1016/j.cardfail.2020.09.474. Epub 2020 Oct 7.
7
Performance of the HFPEF and the HFA-PEFF scores for the diagnosis of heart failure with preserved ejection fraction in Japanese patients: A report from the Japanese multicenter registry.HFPEF 和 HFA-PEFF 评分在日本心力衰竭保留射血分数患者诊断中的表现:来自日本多中心注册研究的报告。
Int J Cardiol. 2021 Nov 1;342:43-48. doi: 10.1016/j.ijcard.2021.08.001. Epub 2021 Aug 5.
8
Evaluation the value of HFPEF score and HFA-PEFF step E score in the diagnosis of heart failure with preserved ejection fraction.评估 HFPEF 评分和 HFA-PEFF 步 E 评分在诊断射血分数保留心力衰竭中的价值。
Acta Cardiol. 2023 Sep;78(7):790-795. doi: 10.1080/00015385.2023.2221149. Epub 2023 Jun 15.
9
H2FPEF Score as a Prognostic Value in HFpEF Patients.H2FPEF 评分作为 HFpEF 患者的预后价值。
Am J Hypertens. 2019 Oct 16;32(11):1082-1090. doi: 10.1093/ajh/hpz108.
10
The HFPEF and HFA-PEFF algorithms for predicting exercise intolerance and abnormal hemodynamics in heart failure with preserved ejection fraction.HFPEF 和 HFA-PEFF 算法用于预测射血分数保留心力衰竭患者的运动不耐受和异常血液动力学。
Sci Rep. 2022 Jan 7;12(1):13. doi: 10.1038/s41598-021-03974-6.

本文引用的文献

1
NT-proBNP for Heart Failure Screening in Primary Care in an Eastern European Country: What We Know and Proposed Steps.用于东欧国家初级保健中心力衰竭筛查的N末端B型利钠肽原:我们所了解的情况及建议措施
Epidemiologia (Basel). 2025 Jan 15;6(1):2. doi: 10.3390/epidemiologia6010002.
2
Utility of Kansas City Cardiomyopathy Questionnaire (KCCQ) in Assessing Quality of Life among Patients with Heart Failure Undergoing Exercise Training Rehabilitation: A Systematic Review.堪萨斯城心肌病问卷(KCCQ)在评估接受运动训练康复的心力衰竭患者生活质量中的应用:一项系统综述。
Diseases. 2024 Mar 22;12(4):64. doi: 10.3390/diseases12040064.
3
Burden of Chronic Heart Failure in Romania.
罗马尼亚慢性心力衰竭的负担。
Healthcare (Basel). 2022 Jan 6;10(1):107. doi: 10.3390/healthcare10010107.
4
HFPEF score predicts 1-year rehospitalisation of patients with heart failure with preserved ejection fraction.HFPEF 评分可预测射血分数保留的心力衰竭患者 1 年内再住院的情况。
Postgrad Med J. 2021 Mar;97(1145):164-167. doi: 10.1136/postgradmedj-2019-137434. Epub 2020 Feb 29.
5
Quality of life of chronic heart failure patients: a systematic review and meta-analysis.慢性心力衰竭患者的生活质量:系统评价和荟萃分析。
Heart Fail Rev. 2020 Nov;25(6):993-1006. doi: 10.1007/s10741-019-09890-2.
6
Health Policies in Romania to Reduce the Mortality Caused by Cardiovascular Diseases.罗马尼亚降低心血管疾病死亡率的卫生政策。
Int J Environ Res Public Health. 2019 Aug 24;16(17):3080. doi: 10.3390/ijerph16173080.
7
H2FPEF Score as a Prognostic Value in HFpEF Patients.H2FPEF 评分作为 HFpEF 患者的预后价值。
Am J Hypertens. 2019 Oct 16;32(11):1082-1090. doi: 10.1093/ajh/hpz108.
8
Non-cardiac comorbidities and mortality in patients with heart failure with reduced vs. preserved ejection fraction: a study using the Swedish Heart Failure Registry.射血分数降低型与射血分数保留型心力衰竭患者的非心脏合并症与死亡率:一项使用瑞典心力衰竭注册研究的分析。
Clin Res Cardiol. 2019 Sep;108(9):1025-1033. doi: 10.1007/s00392-019-01430-0. Epub 2019 Feb 20.
9
Factors associated with health-related quality of life in stable ambulatory congestive heart failure patients: Systematic review.与稳定的门诊充血性心力衰竭患者健康相关生活质量相关的因素:系统评价。
Eur J Prev Cardiol. 2018 Mar;25(5):472-481. doi: 10.1177/2047487318755795. Epub 2018 Jan 31.
10
Heart failure.心力衰竭。
Lancet. 2017 Oct 28;390(10106):1981-1995. doi: 10.1016/S0140-6736(17)31071-1. Epub 2017 Apr 28.